Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 9, Issue 9
High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
XML
Clinical/translational cancer immunotherapy
Original research
High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4
+
and CD8
+
neoantigen-specific T cells to promote antitumor immunity
Online download statistics by month:
Online download statistics by month: September 2021 to May 2022
Abstract
Full
Pdf
Sep 2021
1019
1021
296
Oct 2021
229
228
80
Nov 2021
171
171
47
Dec 2021
101
102
42
Jan 2022
86
87
43
Feb 2022
74
76
74
Mar 2022
108
110
56
Apr 2022
80
82
41
May 2022
98
100
57
Total
1966
1977
736
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?